BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8799651)

  • 21. Metabolic syndrome and the menopause.
    Kaaja RJ
    Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gestational diabetes, pregnancy hypertension, and late vascular disease.
    Carpenter MW
    Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperinsulinemia. Current thinking on cardiovascular risks].
    Bühler FR; Ritz E; Rett K
    Fortschr Med Suppl; 1990; 93():3-11. PubMed ID: 2202621
    [No Abstract]   [Full Text] [Related]  

  • 27. C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.
    Nesto R
    Diabet Med; 2004 Aug; 21(8):810-7. PubMed ID: 15270782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of insulin resistance in human disease (syndrome X): an expanded definition.
    Reaven GM
    Annu Rev Med; 1993; 44():121-31. PubMed ID: 8476236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 'thrifty' hypotheses: clinical and epidemiological significance for non-insulin-dependent diabetes mellitus and cardiovascular disease risk factors.
    Chukwuma C; Tuomilehto J
    J Cardiovasc Risk; 1998 Feb; 5(1):11-23. PubMed ID: 9816551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance and its impact on the approach to therapy of type 2 diabetes.
    Laakso M
    Int J Clin Pract Suppl; 2001 Sep; (121):8-12. PubMed ID: 11594246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-resistance syndrome and cardiovascular complications of non-insulin-dependent diabetes mellitus.
    Fontbonne A
    Diabetes Metab; 1996 Oct; 22(5):305-13. PubMed ID: 8896991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone and the metabolic syndrome.
    Johannsson G; Bengtsson BA
    J Endocrinol Invest; 1999; 22(5 Suppl):41-6. PubMed ID: 10442570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical manifestations of the insulin resistance syndrome. The hormonal-metabolic syndrome X, the 5H syndrome and their etiopathogenesis].
    Hrnciar J
    Vnitr Lek; 1995 Feb; 41(2):92-8. PubMed ID: 7725646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].
    Jaffiol C; Rouard M; Macari F; Lautier C; Ait el Mkadem S; Méchaly I; Brun JF; Renard E; Cros G; Bringer J; Grigorescu F
    Bull Acad Natl Med; 1999; 183(9):1761-75; discussion 1775-7. PubMed ID: 10987057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance as an intermediary endpoint.
    Lithell HO
    Blood Press Suppl; 1997; 2():108-12. PubMed ID: 9495638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative effects of chronic inflammatory periodontal disease on diabetes mellitus.
    Nishimura F; Kono T; Fujimoto C; Iwamoto Y; Murayama Y
    J Int Acad Periodontol; 2000 Apr; 2(2):49-55. PubMed ID: 12666961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Insulin resistance and arterial hypertension].
    Hrnciarová M; Hrnciar J; Jakubíková K
    Vnitr Lek; 1995 Feb; 41(2):111-6. PubMed ID: 7725634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.